Vitamin B6 and Depression in Pregnant and Peri-partum Women

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jun 3, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of vitamin B6 on preventing and treating depression in pregnant women, especially during the time right after giving birth. Postpartum depression is a common issue, affecting about 1 in 10 new mothers, and can lead to mood swings and emotional struggles that are often overlooked. Researchers believe that vitamin B6, which helps with brain function and emotional health, may be a simple way to support mental well-being during this important time.

To participate in the study, women need to be pregnant and between 24 and 28 weeks along, and they should not have any personal history of serious mental health issues like depression or bipolar disorder. Unfortunately, those who are allergic to vitamin B6 cannot join. Participants will take vitamin B6 supplements and help researchers learn more about how different amounts and timing of the vitamin can impact mental health. The study aims to find effective ways to support expectant mothers and ensure they have a healthy and positive experience during pregnancy and after childbirth.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women at 24-28 weeks of gestation
• • Without a personal history of depression, bipolar disorder, schizophrenia, or other mental health conditions.
• Exclusion Criteria:
• • Allergic to Vitamin B6

Trial Officials